June 25, 2021– Tens of millions of people in the U.S. who are living with chronic diseases require access to regular care and support to help them manage their conditions and live their best possible lives. For too many patients of color, those living with disabilities, and those who have low incomes, the broader health care system often falls short in providing them the care … [Read more...]
Research Highlights the Toll of Drug Maker Attacks on 340B, Shows How Hospitals Use Their Savings to Care for Patients
March 23, 2021– Newly released research demonstrates how patients benefit from the 340B drug pricing program in the form of expanded access and improved health outcomes. But there is growing evidence that the actions of six drug companies to cut off 340B discounts for certain drugs is sapping needed resources during the continued COVID-19 pandemic. 340B Health’s annual … [Read more...]
340B Hospitals Are Key to the Pursuit of Health Equity
February 8, 2021– A global pandemic, an economic recession, and social strife in communities across the nation have cast a bright light on the deep racial and ethnic inequities in the U.S., starting a national dialogue that aspires to put us on a path toward real change. President Biden and his administration have made pursuing equity in health care and many other areas of our … [Read more...]
340B DSH Hospitals Provide Three-Quarters of Medicaid Hospital Services
July 16, 2020— New research shows that disproportionate share (DSH) hospitals that participate in the 340B drug pricing program provide 75% of Medicaid hospital services. That figure is even more impressive when you consider that these facilities make up only 43% of all acute care hospitals. This conclusion is one of several key findings in 340B Health’s new report … [Read more...]
340B Is a Cancer Lifeline for the Underserved
June 25, 2020— Although cancer can sicken and kill people of all races and ethnicities, disability statuses, and socioeconomic levels, it is a documented fact that members of certain underserved populations are more likely to have problems accessing cancer treatments and to have worse health outcomes. It is also a documented fact that hospitals participating in the 340B … [Read more...]
Flawed Measures, Appearance of Bias in 340B Study
March 25, 2020 - A new research study published in Health Services Research finds hospitals newly enrolled in the 340B program provide more charity care, by offering more patients discounted care. Specifically, for newly enrolled 340B hospitals, the study finds: The amount of charity care provided increased by nearly 28.9 percent after 340B enrollment. The probability of … [Read more...]
MedPAC Report Addresses Key 340B Questions
March 18, 2020– A new report from a respected, independent congressional advisory panel sheds light on several of the key questions surrounding the 340B drug pricing program. In its March 2020 report to Congress, the Medicare Payment Advisory Commission (MedPAC) examined whether participation in the 340B program leads to higher drug spending for Medicare patients with five … [Read more...]